ARADHANA SARIN Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ARADHANA SARIN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ARADHANA SARIN. ARADHANA SARIN is Chief Strategy & Business Off in ALEXION PHARMACEUTICALS, INC. ($ALXN) and EVP, CFO in ALEXION PHARMACEUTICALS, INC. ($ALXN) and Director in ORASURE TECHNOLOGIES INC ($OSUR).
Latest Insider Trading Transactions of ARADHANA SARIN
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 02 2021 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Grant | A | 0.00 | 24,473 | 0 | 63,940 | 39.5 K to 63.9 K (+62.01 %) |
Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Payment of Exercise | F | 157.96 | 2,510 | 396,480 | 39,467 | 42 K to 39.5 K (-5.98 %) |
Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Payment of Exercise | F | 157.96 | 6,853 | 1,082,500 | 41,977 | 48.8 K to 42 K (-14.03 %) |
Dec 18 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Grant | A | 0.00 | 15,371 | 0 | 48,830 | 33.5 K to 48.8 K (+45.94 %) |
Dec 01 2020 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Payment of Exercise | F | 124.00 | 1,298 | 160,952 | 33,459 | 34.8 K to 33.5 K (-3.73 %) |
Dec 04 2019 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | EVP, CFO | Payment of Exercise | F | 113.20 | 5,441 | 615,921 | 24,760 | 30.2 K to 24.8 K (-18.02 %) |
Jun 24 2019 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | Chief Strategy & Bu ... | Sell | S | 132.00 | 578 | 76,296 | 30,201 | 30.8 K to 30.2 K (-1.88 %) |
May 22 2019 | OSUR | ORASURE TECHNOLOGI ... | SARIN ARADHANA | Director | Grant | A | 8.48 | 12,382 | 104,999 | 16,865 | 4.5 K to 16.9 K (+276.20 %) |
May 07 2019 | OSUR | ORASURE TECHNOLOGI ... | SARIN ARADHANA | Director | Payment of Exercise | F | 9.88 | 1,661 | 16,415 | 4,483 | 6.1 K to 4.5 K (-27.03 %) |
Mar 05 2019 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | Chief Strategy & Bu ... | Grant | A | 0.00 | 8,250 | 0 | 30,779 | 22.5 K to 30.8 K (+36.62 %) |
Mar 04 2019 | ALXN | ALEXION PHARMACEUT ... | SARIN ARADHANA | Chief Strategy & Bu ... | Payment of Exercise | F | 132.92 | 267 | 35,490 | 22,529 | 22.8 K to 22.5 K (-1.17 %) |
May 10 2018 | OSUR | ORASURE TECHNOLOGI ... | SARIN ARADHANA | Director | Grant | A | 0.00 | 6,144 | 0 | 6,144 | 0 to 6.1 K |
Page: 1